Homology Medicines Inc (NAS:FIXX)
$ 0.9347 0.0071 (0.77%) Market Cap: 3.02 Mil Enterprise Value: -78.32 Mil PE Ratio: 0 PB Ratio: 0.04 GF Score: 32/100

Homology Medicines Inc at Stifel Healthcare Conference Transcript

Nov 15, 2022 / 09:10PM GMT
Release Date Price: $31.86 (+10.63%)
Dae Gon Ha
Stifel Financial Corp. - Analyst

All right. Good afternoon, everyone. Thanks for joining this next session. My name is Dae Gon Ha, one of the biotech analysts here at Stifel. With me for the next half hour-ish, we have Homology Medicines. And with me on stage, we've got the President and CEO, Albert Seymour. So Albert, thanks very much for joining us. This is my first time seeing you after you became the CEO. So thanks for that.

Questions & Answers

Dae Gon Ha
Stifel Financial Corp. - Analyst

Maybe if we can just start off with a brief overview of Homology, programs that you've got going in the catalysts for the next 6 to 12 months-ish.

Albert Seymour
Homology Medicines, Inc. - President & CEO

Yes, happy to dig on. So within the catalysts and within the company right now, we're continuing to progress. We have two programs that we're really excited about that are in Phase 1 right now. Ones are the first in-vivo gene editing program for PKU, HMI-103; again in Phase 1. In parallel with that,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot